OSTX Net Receivables from 2010 to 2025

OSTX Stock   2.23  0.24  12.06%   
OS Therapies Net Receivables yearly trend continues to be fairly stable with very little volatility. Net Receivables will likely drop to 978.97 in 2025. During the period from 2010 to 2025, OS Therapies Net Receivables regression line of annual values had r-squared of  0.56 and arithmetic mean of  173,572. View All Fundamentals
 
Net Receivables  
First Reported
2010-12-31
Previous Quarter
K
Current Value
978.97
Quarterly Volatility
102.9 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check OS Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OS Therapies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.1 K, Selling General Administrative of 1 M or Other Operating Expenses of 3.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. OSTX financial statements analysis is a perfect complement when working with OS Therapies Valuation or Volatility modules.
  
Check out the analysis of OS Therapies Correlation against competitors.

Latest OS Therapies' Net Receivables Growth Pattern

Below is the plot of the Net Receivables of OS Therapies Incorporated over the last few years. It is OS Therapies' Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OS Therapies' overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
1.1K1.0K979.0100%
       Timeline  

OSTX Net Receivables Regression Statistics

Arithmetic Mean173,572
Geometric Mean60,311
Coefficient Of Variation59.26
Mean Deviation86,249
Median231,071
Standard Deviation102,857
Sample Variance10.6B
Range230.1K
R-Value(0.75)
Mean Square Error4.9B
R-Squared0.56
Significance0.0008
Slope(16,236)
Total Sum of Squares158.7B

OSTX Net Receivables History

2025 978.97
2024 1030.5
2022 1145.0

About OS Therapies Financial Statements

OS Therapies investors use historical fundamental indicators, such as OS Therapies' Net Receivables, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in OS Therapies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net ReceivablesK979

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for OSTX Stock Analysis

When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.

Trending Assets

KBDCY
Kingboard Chemical
11.65  0.00  0.00 
PKE
Park Electrochemical
14.04  -0.01  -0.07 
CDXS
Codexis
4.39  0.08  1.86 
CC
Chemours
17.48  0.65  3.86 
CIO-P-A
City Office REIT
18.60  0.19  1.03 
ATHM
Autohome
30.36  0.26  0.86 
FSP
Franklin Street Prop
1.99  -0.01  -0.5 
News Freq…Investor S…